Net gamma exposure for Eli Lilly & Co (LLY) options was positive at the Nov 4, 2026 close, about $230.47M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for LLY, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for LLY, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for LLY, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
LLY Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is LLY gamma exposure positive or negative?
Eli Lilly net gamma exposure was positive on Nov 4, 2026, at $230.47M. It has been positive on 20 of the last 20 trading days.
How has LLY gamma exposure changed recently?
Eli Lilly net gamma exposure went from $137.3M on Oct 7, 2026 to $230.47M on Nov 4, 2026. See the LLY gamma exposure history for a longer view.
What is Eli Lilly & Co?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology.